

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | histone H3-K36 demethylation (GO:0070544) | 4.58100786 |
| 2 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.39107821 |
| 3 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.37842579 |
| 4 | interkinetic nuclear migration (GO:0022027) | 4.18947583 |
| 5 | lysine metabolic process (GO:0006553) | 4.15588630 |
| 6 | lysine catabolic process (GO:0006554) | 4.15588630 |
| 7 | regulation of histone H3-K27 methylation (GO:0061085) | 4.15148992 |
| 8 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.12750037 |
| 9 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.06572367 |
| 10 | histone H3-K9 demethylation (GO:0033169) | 3.87393867 |
| 11 | positive regulation of histone deacetylation (GO:0031065) | 3.80872913 |
| 12 | definitive hemopoiesis (GO:0060216) | 3.80539930 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 3.79031608 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.78040790 |
| 15 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.74886451 |
| 16 | histone lysine demethylation (GO:0070076) | 3.68124949 |
| 17 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.65768377 |
| 18 | dosage compensation (GO:0007549) | 3.59380300 |
| 19 | histone H3-K4 trimethylation (GO:0080182) | 3.58634393 |
| 20 | carnitine shuttle (GO:0006853) | 3.58002157 |
| 21 | urea cycle (GO:0000050) | 3.57195669 |
| 22 | urea metabolic process (GO:0019627) | 3.57195669 |
| 23 | nuclear pore complex assembly (GO:0051292) | 3.56055296 |
| 24 | 2-oxoglutarate metabolic process (GO:0006103) | 3.55449437 |
| 25 | fatty acid transmembrane transport (GO:1902001) | 3.53781172 |
| 26 | histone demethylation (GO:0016577) | 3.51360304 |
| 27 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.50234917 |
| 28 | phospholipid homeostasis (GO:0055091) | 3.49678288 |
| 29 | negative regulation of DNA repair (GO:0045738) | 3.49665086 |
| 30 | embryonic process involved in female pregnancy (GO:0060136) | 3.49332470 |
| 31 | valine metabolic process (GO:0006573) | 3.46085415 |
| 32 | peptidyl-threonine phosphorylation (GO:0018107) | 3.37221159 |
| 33 | NLS-bearing protein import into nucleus (GO:0006607) | 3.37084682 |
| 34 | regulation of cholesterol homeostasis (GO:2000188) | 3.34914068 |
| 35 | homocysteine metabolic process (GO:0050667) | 3.30762356 |
| 36 | peptidyl-threonine modification (GO:0018210) | 3.27118808 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.24058299 |
| 38 | mitotic sister chromatid cohesion (GO:0007064) | 3.23007119 |
| 39 | pre-miRNA processing (GO:0031054) | 3.15294474 |
| 40 | cysteine metabolic process (GO:0006534) | 3.15060766 |
| 41 | kynurenine metabolic process (GO:0070189) | 3.07743805 |
| 42 | peptidyl-lysine trimethylation (GO:0018023) | 3.07713082 |
| 43 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.05507411 |
| 44 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.04085034 |
| 45 | nucleus localization (GO:0051647) | 3.03629755 |
| 46 | nitrogen cycle metabolic process (GO:0071941) | 3.03260860 |
| 47 | histone H3-K4 methylation (GO:0051568) | 3.03132227 |
| 48 | nuclear pore organization (GO:0006999) | 3.01959094 |
| 49 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.00840159 |
| 50 | cellular response to ethanol (GO:0071361) | 2.99045528 |
| 51 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.98741050 |
| 52 | growth hormone receptor signaling pathway (GO:0060396) | 2.97844553 |
| 53 | carnitine transmembrane transport (GO:1902603) | 2.96858760 |
| 54 | carnitine transport (GO:0015879) | 2.96580154 |
| 55 | amino-acid betaine transport (GO:0015838) | 2.96580154 |
| 56 | complement activation, alternative pathway (GO:0006957) | 2.94763865 |
| 57 | mitotic chromosome condensation (GO:0007076) | 2.94206353 |
| 58 | protein demethylation (GO:0006482) | 2.93890903 |
| 59 | protein dealkylation (GO:0008214) | 2.93890903 |
| 60 | regulation of protein activation cascade (GO:2000257) | 2.91096470 |
| 61 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.91010860 |
| 62 | fatty acid homeostasis (GO:0055089) | 2.89575384 |
| 63 | positive regulation of granulocyte differentiation (GO:0030854) | 2.89198415 |
| 64 | positive T cell selection (GO:0043368) | 2.88332145 |
| 65 | positive regulation of fatty acid oxidation (GO:0046321) | 2.85746096 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.85116951 |
| 67 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.82685998 |
| 68 | serine family amino acid catabolic process (GO:0009071) | 2.81949219 |
| 69 | DNA duplex unwinding (GO:0032508) | 2.81242620 |
| 70 | regulation of fatty acid oxidation (GO:0046320) | 2.80740788 |
| 71 | regulation of complement activation (GO:0030449) | 2.80475440 |
| 72 | tricarboxylic acid metabolic process (GO:0072350) | 2.78675471 |
| 73 | peptidyl-lysine dimethylation (GO:0018027) | 2.77101458 |
| 74 | negative regulation of cell size (GO:0045792) | 2.75479292 |
| 75 | negative regulation of cholesterol transport (GO:0032375) | 2.74721569 |
| 76 | negative regulation of sterol transport (GO:0032372) | 2.74721569 |
| 77 | skeletal muscle adaptation (GO:0043501) | 2.73827636 |
| 78 | histone lysine methylation (GO:0034968) | 2.73593699 |
| 79 | glutamate metabolic process (GO:0006536) | 2.73011286 |
| 80 | amino-acid betaine metabolic process (GO:0006577) | 2.72206650 |
| 81 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.71649500 |
| 82 | L-phenylalanine catabolic process (GO:0006559) | 2.71649500 |
| 83 | regulation of necroptotic process (GO:0060544) | 2.71128625 |
| 84 | aspartate family amino acid catabolic process (GO:0009068) | 2.69760082 |
| 85 | regulation of RNA export from nucleus (GO:0046831) | 2.67638717 |
| 86 | mRNA stabilization (GO:0048255) | 2.67104455 |
| 87 | RNA stabilization (GO:0043489) | 2.67104455 |
| 88 | DNA unwinding involved in DNA replication (GO:0006268) | 2.66443182 |
| 89 | DNA geometric change (GO:0032392) | 2.66267065 |
| 90 | acetyl-CoA metabolic process (GO:0006084) | 2.65342522 |
| 91 | positive regulation of lipid catabolic process (GO:0050996) | 2.64407477 |
| 92 | ethanol oxidation (GO:0006069) | 2.64131482 |
| 93 | DNA synthesis involved in DNA repair (GO:0000731) | 2.63883481 |
| 94 | corticosteroid receptor signaling pathway (GO:0031958) | 2.63592536 |
| 95 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.63071381 |
| 96 | L-phenylalanine metabolic process (GO:0006558) | 2.63071381 |
| 97 | iron ion import (GO:0097286) | 2.62031542 |
| 98 | B cell receptor signaling pathway (GO:0050853) | 2.60990096 |
| 99 | negative regulation of fibrinolysis (GO:0051918) | 2.60636123 |
| 100 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.59088950 |
| 101 | positive thymic T cell selection (GO:0045059) | 2.58807236 |
| 102 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.58666355 |
| 103 | cellular modified amino acid catabolic process (GO:0042219) | 2.58560851 |
| 104 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.57384642 |
| 105 | aromatic amino acid family catabolic process (GO:0009074) | 2.57282514 |
| 106 | N-terminal protein amino acid acetylation (GO:0006474) | 2.56472848 |
| 107 | hypotonic response (GO:0006971) | 2.55697015 |
| 108 | glyoxylate metabolic process (GO:0046487) | 2.55555058 |
| 109 | regulation of histone H3-K9 methylation (GO:0051570) | 2.55093084 |
| 110 | protein carboxylation (GO:0018214) | 2.54270505 |
| 111 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.54270505 |
| 112 | histone H3-K9 modification (GO:0061647) | 2.53813358 |
| 113 | tryptophan metabolic process (GO:0006568) | 2.53763104 |
| 114 | negative regulation of histone methylation (GO:0031061) | 2.53484613 |
| 115 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.52380879 |
| 116 | protein export from nucleus (GO:0006611) | 2.52344777 |
| 117 | regulation of translational fidelity (GO:0006450) | 2.51480068 |
| 118 | sulfur amino acid catabolic process (GO:0000098) | 2.51382832 |
| 119 | peptidyl-serine phosphorylation (GO:0018105) | 2.50736167 |
| 120 | cellular response to growth hormone stimulus (GO:0071378) | 2.50110751 |
| 121 | regulation of cholesterol storage (GO:0010885) | 2.49974744 |
| 122 | negative regulation of lipid transport (GO:0032369) | 2.49687334 |
| 123 | myofibril assembly (GO:0030239) | 2.49454843 |
| 124 | pore complex assembly (GO:0046931) | 2.49083930 |
| 125 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.48684112 |
| 126 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.48565508 |
| 127 | indole-containing compound catabolic process (GO:0042436) | 2.48373756 |
| 128 | indolalkylamine catabolic process (GO:0046218) | 2.48373756 |
| 129 | tryptophan catabolic process (GO:0006569) | 2.48373756 |
| 130 | regulation of triglyceride catabolic process (GO:0010896) | 2.47947270 |
| 131 | regulation of gamma-delta T cell activation (GO:0046643) | 2.46522530 |
| 132 | quaternary ammonium group transport (GO:0015697) | 2.45763388 |
| 133 | peptidyl-lysine methylation (GO:0018022) | 2.45708428 |
| 134 | regulation of histone methylation (GO:0031060) | 2.44509823 |
| 135 | protein K48-linked deubiquitination (GO:0071108) | 2.44199531 |
| 136 | glycine metabolic process (GO:0006544) | 2.44141515 |
| 137 | low-density lipoprotein particle clearance (GO:0034383) | 2.43848604 |
| 138 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.43718126 |
| 139 | cellular hyperosmotic response (GO:0071474) | 2.42795931 |
| 140 | protein-lipid complex assembly (GO:0065005) | 2.42060431 |
| 141 | intracellular lipid transport (GO:0032365) | 2.41907821 |
| 142 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.41600715 |
| 143 | negative regulation of necroptotic process (GO:0060546) | 2.41252355 |
| 144 | negative thymic T cell selection (GO:0045060) | 2.41040553 |
| 145 | positive regulation of glycolytic process (GO:0045821) | 2.40623407 |
| 146 | positive regulation of protein deacetylation (GO:0090312) | 2.40147963 |
| 147 | bile acid biosynthetic process (GO:0006699) | 2.39765468 |
| 148 | response to inactivity (GO:0014854) | 2.39700718 |
| 149 | striated muscle atrophy (GO:0014891) | 2.37892663 |
| 150 | muscle filament sliding (GO:0030049) | 2.37748308 |
| 151 | actin-myosin filament sliding (GO:0033275) | 2.37748308 |
| 152 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.37231151 |
| 153 | negative regulation of histone modification (GO:0031057) | 2.36298090 |
| 154 | sister chromatid cohesion (GO:0007062) | 2.35530213 |
| 155 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.35452704 |
| 156 | phosphatidylinositol phosphorylation (GO:0046854) | 2.34854109 |
| 157 | negative T cell selection (GO:0043383) | 2.34594370 |
| 158 | germinal center formation (GO:0002467) | 2.34022762 |
| 159 | histone H4-K16 acetylation (GO:0043984) | 2.33362994 |
| 160 | histone phosphorylation (GO:0016572) | 2.33234567 |
| 161 | plasma lipoprotein particle assembly (GO:0034377) | 2.32974602 |
| 162 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.32863791 |
| 163 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.32586852 |
| 164 | megakaryocyte development (GO:0035855) | 2.32467190 |
| 165 | nucleus organization (GO:0006997) | 2.32342364 |
| 166 | positive regulation of myotube differentiation (GO:0010831) | 2.31819580 |
| 167 | biotin metabolic process (GO:0006768) | 2.30994017 |
| 168 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.30363944 |
| 169 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.30217275 |
| 170 | regulation of protein polyubiquitination (GO:1902914) | 2.30131458 |
| 171 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.30127361 |
| 172 | positive regulation of B cell differentiation (GO:0045579) | 2.29659312 |
| 173 | regulation of relaxation of muscle (GO:1901077) | 2.29377942 |
| 174 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.29001949 |
| 175 | cell-substrate adherens junction assembly (GO:0007045) | 2.28895505 |
| 176 | focal adhesion assembly (GO:0048041) | 2.28895505 |
| 177 | fatty acid beta-oxidation (GO:0006635) | 2.28887769 |
| 178 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.28620466 |
| 179 | adherens junction assembly (GO:0034333) | 2.28403874 |
| 180 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.28285816 |
| 181 | response to muramyl dipeptide (GO:0032495) | 2.26300736 |
| 182 | establishment of nucleus localization (GO:0040023) | 2.25928287 |
| 183 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.25565445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.68151152 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.12757776 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.50067338 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.29717434 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.18920077 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.13113624 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.01099862 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.86308046 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.69931613 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.55884027 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.55281794 |
| 12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.47386043 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.41561256 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.25803210 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.18424810 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.08477705 |
| 17 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.04091729 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02579049 |
| 19 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.89326023 |
| 20 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.89078968 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.88621158 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.86755305 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.86396974 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.83114294 |
| 25 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.82795641 |
| 26 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.81181324 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77544941 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.70787525 |
| 29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.70648192 |
| 30 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67422567 |
| 31 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.66758990 |
| 32 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.66597296 |
| 33 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.64143129 |
| 34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.63419280 |
| 35 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.61662170 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.59510158 |
| 37 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.53880348 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.53302909 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51776552 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.48757141 |
| 41 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.42344015 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41056487 |
| 43 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.39524562 |
| 44 | * MAF_26560356_Chip-Seq_TH1_Human | 1.39473199 |
| 45 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.38602100 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.37411115 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.36058945 |
| 48 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.36048310 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35979000 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.33719876 |
| 51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.32850564 |
| 52 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.32413041 |
| 53 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.31737014 |
| 54 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31564973 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31519277 |
| 56 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.31081776 |
| 57 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.29250368 |
| 58 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.29250368 |
| 59 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.28807866 |
| 60 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.27621979 |
| 61 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.26919204 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26650592 |
| 63 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26512578 |
| 64 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25515747 |
| 65 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24931366 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22856118 |
| 67 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22697178 |
| 68 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.22562424 |
| 69 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.22416707 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20768637 |
| 71 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20605719 |
| 72 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.20144598 |
| 73 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.19887110 |
| 74 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.19412956 |
| 75 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19242576 |
| 76 | MYB_26560356_Chip-Seq_TH1_Human | 1.18511438 |
| 77 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.18111830 |
| 78 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17681490 |
| 79 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.17096055 |
| 80 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.15676418 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15441952 |
| 82 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.14392821 |
| 83 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13798914 |
| 84 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.13648417 |
| 85 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.13200944 |
| 86 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13147538 |
| 87 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.12559579 |
| 88 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11992227 |
| 89 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.11762526 |
| 90 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11558128 |
| 91 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.10776446 |
| 92 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.09885114 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.09885114 |
| 94 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09394580 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09141055 |
| 96 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08084217 |
| 97 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08026218 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07761612 |
| 99 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06308687 |
| 100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06020525 |
| 101 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05294639 |
| 102 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05272041 |
| 103 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05192917 |
| 104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04648892 |
| 105 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04322966 |
| 106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04081356 |
| 107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03624164 |
| 108 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.03513788 |
| 109 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02612511 |
| 110 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02032600 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01940936 |
| 112 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00955173 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00791662 |
| 114 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00570140 |
| 115 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00557222 |
| 116 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00193144 |
| 117 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.00025818 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99600997 |
| 119 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98594424 |
| 120 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98550929 |
| 121 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98151510 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97512325 |
| 123 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.97485495 |
| 124 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97178747 |
| 125 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97102246 |
| 126 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96862752 |
| 127 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96527456 |
| 128 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96346809 |
| 129 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.95933983 |
| 130 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95872736 |
| 131 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.95855469 |
| 132 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95749373 |
| 133 | MYB_26560356_Chip-Seq_TH2_Human | 0.94548859 |
| 134 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94002810 |
| 135 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92275075 |
| 136 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91759188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 4.98019370 |
| 2 | MP0005360_urolithiasis | 4.22299604 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.89060879 |
| 4 | MP0002009_preneoplasia | 3.66688124 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.63074921 |
| 6 | MP0005365_abnormal_bile_salt | 3.22543888 |
| 7 | MP0003300_gastrointestinal_ulcer | 3.22368780 |
| 8 | MP0000569_abnormal_digit_pigmentation | 3.13242324 |
| 9 | MP0003252_abnormal_bile_duct | 3.05072856 |
| 10 | MP0005451_abnormal_body_composition | 2.91941360 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.83962775 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.64355095 |
| 13 | MP0004130_abnormal_muscle_cell | 2.35380600 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.18678061 |
| 15 | MP0005076_abnormal_cell_differentiation | 2.18203790 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.11194567 |
| 17 | MP0008961_abnormal_basal_metabolism | 1.99417031 |
| 18 | MP0005409_darkened_coat_color | 1.96470920 |
| 19 | MP0005666_abnormal_adipose_tissue | 1.93500683 |
| 20 | MP0003221_abnormal_cardiomyocyte_apopto | 1.84784738 |
| 21 | MP0005670_abnormal_white_adipose | 1.84188922 |
| 22 | MP0004185_abnormal_adipocyte_glucose | 1.79592523 |
| 23 | MP0000609_abnormal_liver_physiology | 1.74555987 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.74310994 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.74282751 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.69498845 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.64960589 |
| 28 | MP0001661_extended_life_span | 1.59215970 |
| 29 | MP0000749_muscle_degeneration | 1.56943949 |
| 30 | MP0000759_abnormal_skeletal_muscle | 1.53073158 |
| 31 | MP0003828_pulmonary_edema | 1.50551062 |
| 32 | MP0003045_fibrosis | 1.46529181 |
| 33 | MP0009840_abnormal_foam_cell | 1.45659477 |
| 34 | MP0010307_abnormal_tumor_latency | 1.45266798 |
| 35 | MP0003111_abnormal_nucleus_morphology | 1.42730673 |
| 36 | MP0000733_abnormal_muscle_development | 1.42117892 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.41015760 |
| 38 | MP0004145_abnormal_muscle_electrophysio | 1.39725209 |
| 39 | MP0010630_abnormal_cardiac_muscle | 1.38518572 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.38203277 |
| 41 | MP0005375_adipose_tissue_phenotype | 1.38133449 |
| 42 | MP0002332_abnormal_exercise_endurance | 1.33922290 |
| 43 | MP0002106_abnormal_muscle_physiology | 1.33350286 |
| 44 | MP0004087_abnormal_muscle_fiber | 1.31720776 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.28791118 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.28298751 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.26052180 |
| 48 | MP0003077_abnormal_cell_cycle | 1.25560672 |
| 49 | MP0003303_peritoneal_inflammation | 1.25116777 |
| 50 | MP0005332_abnormal_amino_acid | 1.24865517 |
| 51 | MP0002118_abnormal_lipid_homeostasis | 1.24046245 |
| 52 | MP0001666_abnormal_nutrient_absorption | 1.20989344 |
| 53 | MP0008260_abnormal_autophagy | 1.20077448 |
| 54 | MP0009672_abnormal_birth_weight | 1.16815480 |
| 55 | MP0002269_muscular_atrophy | 1.15663607 |
| 56 | MP0010094_abnormal_chromosome_stability | 1.13801372 |
| 57 | MP0000350_abnormal_cell_proliferation | 1.13580884 |
| 58 | MP0005621_abnormal_cell_physiology | 1.12914632 |
| 59 | MP0003868_abnormal_feces_composition | 1.12814389 |
| 60 | MP0006138_congestive_heart_failure | 1.10550563 |
| 61 | MP0002971_abnormal_brown_adipose | 1.09436641 |
| 62 | MP0002398_abnormal_bone_marrow | 1.09187185 |
| 63 | MP0004084_abnormal_cardiac_muscle | 1.08889398 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.08863933 |
| 65 | MP0009278_abnormal_bone_marrow | 1.06527693 |
| 66 | MP0003091_abnormal_cell_migration | 1.06245195 |
| 67 | MP0002928_abnormal_bile_duct | 1.05269951 |
| 68 | MP0005023_abnormal_wound_healing | 1.04537843 |
| 69 | MP0000598_abnormal_liver_morphology | 1.04134300 |
| 70 | MP0005369_muscle_phenotype | 1.03139608 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 1.02842067 |
| 72 | MP0002086_abnormal_extraembryonic_tissu | 1.02425778 |
| 73 | MP0002006_tumorigenesis | 1.02172468 |
| 74 | MP0004197_abnormal_fetal_growth/weight/ | 1.01986998 |
| 75 | MP0000751_myopathy | 1.00533219 |
| 76 | MP0004484_altered_response_of | 1.00517454 |
| 77 | MP0000747_muscle_weakness | 0.99796756 |
| 78 | MP0002168_other_aberrant_phenotype | 0.99219422 |
| 79 | MP0002088_abnormal_embryonic_growth/wei | 0.99140549 |
| 80 | MP0002254_reproductive_system_inflammat | 0.99078374 |
| 81 | MP0005083_abnormal_biliary_tract | 0.99004900 |
| 82 | MP0003984_embryonic_growth_retardation | 0.98771260 |
| 83 | MP0004381_abnormal_hair_follicle | 0.98373062 |
| 84 | MP0003890_abnormal_embryonic-extraembry | 0.96895299 |
| 85 | MP0009780_abnormal_chondrocyte_physiolo | 0.96237356 |
| 86 | MP0000003_abnormal_adipose_tissue | 0.95890031 |
| 87 | MP0003943_abnormal_hepatobiliary_system | 0.95874447 |
| 88 | MP0001851_eye_inflammation | 0.95639465 |
| 89 | MP0000371_diluted_coat_color | 0.94229160 |
| 90 | MP0001697_abnormal_embryo_size | 0.93901483 |
| 91 | MP0003646_muscle_fatigue | 0.91556911 |
| 92 | MP0009643_abnormal_urine_homeostasis | 0.91542543 |
| 93 | MP0001915_intracranial_hemorrhage | 0.91214789 |
| 94 | MP0009115_abnormal_fat_cell | 0.89027258 |
| 95 | MP0009703_decreased_birth_body | 0.87882183 |
| 96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86772565 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 0.86019052 |
| 98 | MP0002722_abnormal_immune_system | 0.85866767 |
| 99 | MP0005334_abnormal_fat_pad | 0.83995734 |
| 100 | MP0001835_abnormal_antigen_presentation | 0.83407023 |
| 101 | MP0001672_abnormal_embryogenesis/_devel | 0.82043772 |
| 102 | MP0005380_embryogenesis_phenotype | 0.82043772 |
| 103 | MP0000266_abnormal_heart_morphology | 0.81733883 |
| 104 | MP0002080_prenatal_lethality | 0.81223020 |
| 105 | MP0001545_abnormal_hematopoietic_system | 0.81210146 |
| 106 | MP0005397_hematopoietic_system_phenotyp | 0.81210146 |
| 107 | MP0000689_abnormal_spleen_morphology | 0.81125565 |
| 108 | MP0005330_cardiomyopathy | 0.79059364 |
| 109 | MP0001730_embryonic_growth_arrest | 0.78110062 |
| 110 | MP0004264_abnormal_extraembryonic_tissu | 0.77382134 |
| 111 | MP0001853_heart_inflammation | 0.77364099 |
| 112 | MP0004957_abnormal_blastocyst_morpholog | 0.77248161 |
| 113 | MP0000428_abnormal_craniofacial_morphol | 0.77097183 |
| 114 | MP0002970_abnormal_white_adipose | 0.75867967 |
| 115 | MP0002136_abnormal_kidney_physiology | 0.75833962 |
| 116 | MP0005384_cellular_phenotype | 0.75396743 |
| 117 | MP0008007_abnormal_cellular_replicative | 0.75334707 |
| 118 | MP0004019_abnormal_vitamin_homeostasis | 0.75314410 |
| 119 | MP0005310_abnormal_salivary_gland | 0.75164907 |
| 120 | MP0005266_abnormal_metabolism | 0.74799968 |
| 121 | MP0010678_abnormal_skin_adnexa | 0.74284332 |
| 122 | MP0002108_abnormal_muscle_morphology | 0.74207613 |
| 123 | MP0008775_abnormal_heart_ventricle | 0.74087853 |
| 124 | MP0003656_abnormal_erythrocyte_physiolo | 0.73407312 |
| 125 | MP0004947_skin_inflammation | 0.73115533 |
| 126 | MP0003763_abnormal_thymus_physiology | 0.72697196 |
| 127 | MP0004233_abnormal_muscle_weight | 0.72675389 |
| 128 | MP0002128_abnormal_blood_circulation | 0.72475800 |
| 129 | MP0008438_abnormal_cutaneous_collagen | 0.71270025 |
| 130 | MP0008770_decreased_survivor_rate | 0.70379799 |
| 131 | MP0001849_ear_inflammation | 0.69563919 |
| 132 | MP0004036_abnormal_muscle_relaxation | 0.68589849 |
| 133 | MP0002925_abnormal_cardiovascular_devel | 0.68363661 |
| 134 | MP0003172_abnormal_lysosome_physiology | 0.68106556 |
| 135 | MP0001756_abnormal_urination | 0.68061335 |
| 136 | MP0005464_abnormal_platelet_physiology | 0.67060066 |
| 137 | MP0003279_aneurysm | 0.65139404 |
| 138 | MP0000604_amyloidosis | 0.63456497 |
| 139 | MP0009763_increased_sensitivity_to | 0.63069192 |
| 140 | MP0003453_abnormal_keratinocyte_physiol | 0.62434467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 4.05616196 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 4.03843490 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.96032892 |
| 4 | Subaortic stenosis (HP:0001682) | 3.47697533 |
| 5 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.47697533 |
| 6 | Deep venous thrombosis (HP:0002625) | 3.38683096 |
| 7 | Abnormality of the fingertips (HP:0001211) | 3.23409735 |
| 8 | Papillary thyroid carcinoma (HP:0002895) | 3.19898869 |
| 9 | Cerebral aneurysm (HP:0004944) | 2.95130816 |
| 10 | Macroorchidism (HP:0000053) | 2.94786081 |
| 11 | Acute myeloid leukemia (HP:0004808) | 2.87043147 |
| 12 | Complement deficiency (HP:0004431) | 2.83917885 |
| 13 | Xanthomatosis (HP:0000991) | 2.71205756 |
| 14 | Hypoalphalipoproteinemia (HP:0003233) | 2.70420518 |
| 15 | Dysmetric saccades (HP:0000641) | 2.68515150 |
| 16 | Type 1 muscle fiber predominance (HP:0003803) | 2.68388370 |
| 17 | Myocardial infarction (HP:0001658) | 2.67089713 |
| 18 | Neonatal hypoglycemia (HP:0001998) | 2.65381912 |
| 19 | Intrahepatic cholestasis (HP:0001406) | 2.58248601 |
| 20 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.48638277 |
| 21 | Hyporeflexia of lower limbs (HP:0002600) | 2.46621407 |
| 22 | Heterotopia (HP:0002282) | 2.44246941 |
| 23 | Viral hepatitis (HP:0006562) | 2.44118066 |
| 24 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.40876024 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.36865086 |
| 26 | Mitral valve prolapse (HP:0001634) | 2.34212591 |
| 27 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.34001458 |
| 28 | Subacute progressive viral hepatitis (HP:0006572) | 2.33798211 |
| 29 | Aortic aneurysm (HP:0004942) | 2.33710971 |
| 30 | Sandal gap (HP:0001852) | 2.33664507 |
| 31 | Esophageal varix (HP:0002040) | 2.33354385 |
| 32 | Aneurysm (HP:0002617) | 2.32692756 |
| 33 | Difficulty running (HP:0009046) | 2.32547557 |
| 34 | Dislocated radial head (HP:0003083) | 2.30758418 |
| 35 | Deep philtrum (HP:0002002) | 2.28998548 |
| 36 | Epidermoid cyst (HP:0200040) | 2.27981569 |
| 37 | Hypolipoproteinemia (HP:0010981) | 2.27003632 |
| 38 | Hematochezia (HP:0002573) | 2.25599972 |
| 39 | Hyperacusis (HP:0010780) | 2.24928891 |
| 40 | Urethral obstruction (HP:0000796) | 2.23855805 |
| 41 | Lymphangioma (HP:0100764) | 2.22567032 |
| 42 | Fatigue (HP:0012378) | 2.19487498 |
| 43 | Increased connective tissue (HP:0009025) | 2.19133300 |
| 44 | Spinal cord lesions (HP:0100561) | 2.17233917 |
| 45 | Syringomyelia (HP:0003396) | 2.17233917 |
| 46 | Spastic diplegia (HP:0001264) | 2.15903562 |
| 47 | Long clavicles (HP:0000890) | 2.15728715 |
| 48 | Overgrowth (HP:0001548) | 2.14586342 |
| 49 | Narrow palate (HP:0000189) | 2.13709364 |
| 50 | Ketosis (HP:0001946) | 2.12818558 |
| 51 | Elfin facies (HP:0004428) | 2.12040054 |
| 52 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.11874525 |
| 53 | Pseudobulbar signs (HP:0002200) | 2.10748811 |
| 54 | Distal lower limb amyotrophy (HP:0008944) | 2.10334386 |
| 55 | Hyperammonemia (HP:0001987) | 2.10091704 |
| 56 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.08815830 |
| 57 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.06807958 |
| 58 | Cystic hygroma (HP:0000476) | 2.06552903 |
| 59 | Hyperkalemia (HP:0002153) | 2.06215990 |
| 60 | Hyperlipoproteinemia (HP:0010980) | 2.05042302 |
| 61 | EMG: myopathic abnormalities (HP:0003458) | 2.04600863 |
| 62 | Hyperglycinuria (HP:0003108) | 2.03911126 |
| 63 | Ankyloglossia (HP:0010296) | 2.03044772 |
| 64 | Frequent falls (HP:0002359) | 2.00772523 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.00751254 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.00482782 |
| 67 | Relative macrocephaly (HP:0004482) | 2.00083461 |
| 68 | Abnormality of the radial head (HP:0003995) | 1.99848065 |
| 69 | Abnormality of the lower motor neuron (HP:0002366) | 1.98426936 |
| 70 | Hypoglycemic coma (HP:0001325) | 1.97209556 |
| 71 | Hypobetalipoproteinemia (HP:0003563) | 1.97108286 |
| 72 | Distal arthrogryposis (HP:0005684) | 1.96860259 |
| 73 | Rectal prolapse (HP:0002035) | 1.96146519 |
| 74 | T lymphocytopenia (HP:0005403) | 1.96037984 |
| 75 | Enlarged penis (HP:0000040) | 1.95637841 |
| 76 | Long eyelashes (HP:0000527) | 1.94978074 |
| 77 | Germ cell neoplasia (HP:0100728) | 1.94166919 |
| 78 | Abnormality of the calcaneus (HP:0008364) | 1.93711560 |
| 79 | Abnormality of complement system (HP:0005339) | 1.93475009 |
| 80 | Ulnar deviation of the wrist (HP:0003049) | 1.92722079 |
| 81 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.92532827 |
| 82 | Increased variability in muscle fiber diameter (HP:0003557) | 1.92369787 |
| 83 | Increased density of long bones (HP:0006392) | 1.91897340 |
| 84 | Vertebral arch anomaly (HP:0008438) | 1.91157180 |
| 85 | Renovascular hypertension (HP:0100817) | 1.90960810 |
| 86 | Back pain (HP:0003418) | 1.90036658 |
| 87 | Insidious onset (HP:0003587) | 1.89129484 |
| 88 | Termporal pattern (HP:0011008) | 1.89129484 |
| 89 | Calf muscle hypertrophy (HP:0008981) | 1.88968067 |
| 90 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.87597198 |
| 91 | Cubitus valgus (HP:0002967) | 1.86002737 |
| 92 | Exercise-induced myalgia (HP:0003738) | 1.85741498 |
| 93 | Asymmetry of the thorax (HP:0001555) | 1.85439595 |
| 94 | Exercise-induced muscle cramps (HP:0003710) | 1.85353687 |
| 95 | Myoglobinuria (HP:0002913) | 1.84082675 |
| 96 | Mitral stenosis (HP:0001718) | 1.84028296 |
| 97 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.83961576 |
| 98 | Osteolytic defects of the hand bones (HP:0009699) | 1.83961576 |
| 99 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.83813565 |
| 100 | Abnormality of glycine metabolism (HP:0010895) | 1.83813565 |
| 101 | Submucous cleft hard palate (HP:0000176) | 1.83172492 |
| 102 | Slow saccadic eye movements (HP:0000514) | 1.82563993 |
| 103 | Acanthocytosis (HP:0001927) | 1.81806877 |
| 104 | Abnormality of the common coagulation pathway (HP:0010990) | 1.81296126 |
| 105 | Resting tremor (HP:0002322) | 1.81122623 |
| 106 | Low anterior hairline (HP:0000294) | 1.78822150 |
| 107 | Flat acetabular roof (HP:0003180) | 1.78653861 |
| 108 | Shallow orbits (HP:0000586) | 1.78323394 |
| 109 | EMG: neuropathic changes (HP:0003445) | 1.77820477 |
| 110 | Rimmed vacuoles (HP:0003805) | 1.76545186 |
| 111 | Ketoacidosis (HP:0001993) | 1.76110513 |
| 112 | Astrocytoma (HP:0009592) | 1.75435357 |
| 113 | Abnormality of the astrocytes (HP:0100707) | 1.75435357 |
| 114 | Myopathic facies (HP:0002058) | 1.75415182 |
| 115 | Upper limb amyotrophy (HP:0009129) | 1.74036890 |
| 116 | Distal upper limb amyotrophy (HP:0007149) | 1.74036890 |
| 117 | Thyroid carcinoma (HP:0002890) | 1.73558816 |
| 118 | Truncal obesity (HP:0001956) | 1.73183605 |
| 119 | Hypercholesterolemia (HP:0003124) | 1.73165777 |
| 120 | Obsessive-compulsive behavior (HP:0000722) | 1.72287011 |
| 121 | Colitis (HP:0002583) | 1.72199305 |
| 122 | Short chin (HP:0000331) | 1.72064831 |
| 123 | Curly hair (HP:0002212) | 1.71918610 |
| 124 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.71512249 |
| 125 | Gastrointestinal carcinoma (HP:0002672) | 1.71512249 |
| 126 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.70672560 |
| 127 | Short 4th metacarpal (HP:0010044) | 1.70672560 |
| 128 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.70038181 |
| 129 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.69867906 |
| 130 | Abnormality of purine metabolism (HP:0004352) | 1.69661731 |
| 131 | Right ventricular cardiomyopathy (HP:0011663) | 1.69218953 |
| 132 | Abnormal foot bone ossification (HP:0010675) | 1.69185110 |
| 133 | Uterine leiomyosarcoma (HP:0002891) | 1.69173280 |
| 134 | Leiomyosarcoma (HP:0100243) | 1.69173280 |
| 135 | Abnormality of the Achilles tendon (HP:0005109) | 1.68994879 |
| 136 | Volvulus (HP:0002580) | 1.68103239 |
| 137 | Abnormality of chromosome segregation (HP:0002916) | 1.66997505 |
| 138 | Disproportionate tall stature (HP:0001519) | 1.66960409 |
| 139 | Ependymoma (HP:0002888) | 1.66016273 |
| 140 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.65836030 |
| 141 | Abnormality of T cell number (HP:0011839) | 1.65619506 |
| 142 | Hypoplastic ischia (HP:0003175) | 1.64644838 |
| 143 | Skin nodule (HP:0200036) | 1.64401771 |
| 144 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.63855415 |
| 145 | Bladder carcinoma (HP:0002862) | 1.63605437 |
| 146 | Bladder neoplasm (HP:0009725) | 1.63605437 |
| 147 | Coarse hair (HP:0002208) | 1.62299115 |
| 148 | Hand muscle atrophy (HP:0009130) | 1.62164739 |
| 149 | Autoimmune thrombocytopenia (HP:0001973) | 1.62144907 |
| 150 | Hyperglycinemia (HP:0002154) | 1.61696570 |
| 151 | Abnormality of oral frenula (HP:0000190) | 1.61422290 |
| 152 | Muscle fiber splitting (HP:0003555) | 1.61290717 |
| 153 | Abnormality of the 4th metacarpal (HP:0010012) | 1.60948354 |
| 154 | Global brain atrophy (HP:0002283) | 1.60853781 |
| 155 | Broad palm (HP:0001169) | 1.60834488 |
| 156 | Broad metatarsal (HP:0001783) | 1.60630493 |
| 157 | Fibrous tissue neoplasm (HP:0012316) | 1.60336840 |
| 158 | Upper motor neuron abnormality (HP:0002127) | 1.60160005 |
| 159 | Fair hair (HP:0002286) | 1.59411758 |
| 160 | Eczematoid dermatitis (HP:0000976) | 1.59365925 |
| 161 | Large earlobe (HP:0009748) | 1.59335211 |
| 162 | Cortical dysplasia (HP:0002539) | 1.58680911 |
| 163 | Polycythemia (HP:0001901) | 1.58668972 |
| 164 | Deep palmar crease (HP:0006191) | 1.58091244 |
| 165 | Progressive external ophthalmoplegia (HP:0000590) | 1.57811920 |
| 166 | Fibroma (HP:0010614) | 1.57241490 |
| 167 | Cafe-au-lait spot (HP:0000957) | 1.56342236 |
| 168 | Lower limb amyotrophy (HP:0007210) | 1.56284023 |
| 169 | Prominent nose (HP:0000448) | 1.56026934 |
| 170 | Increased CSF protein (HP:0002922) | 1.55703246 |
| 171 | Recurrent viral infections (HP:0004429) | 1.55328651 |
| 172 | Poikilocytosis (HP:0004447) | 1.55026563 |
| 173 | Sparse lateral eyebrow (HP:0005338) | 1.54352017 |
| 174 | Hamartoma of the eye (HP:0010568) | 1.53950896 |
| 175 | Hepatitis (HP:0012115) | 1.53892663 |
| 176 | Ulnar bowing (HP:0003031) | 1.53850145 |
| 177 | Gout (HP:0001997) | 1.53759779 |
| 178 | Increased mean platelet volume (HP:0011877) | 1.53561596 |
| 179 | Areflexia of lower limbs (HP:0002522) | 1.53128131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.52646238 |
| 2 | PKN2 | 3.49679579 |
| 3 | CDK12 | 3.42276501 |
| 4 | EEF2K | 2.95674649 |
| 5 | CAMK1D | 2.85123845 |
| 6 | SIK1 | 2.69019397 |
| 7 | PRPF4B | 2.61057211 |
| 8 | TTN | 2.58295294 |
| 9 | CAMK1G | 2.55435142 |
| 10 | LATS1 | 2.50559196 |
| 11 | MAP3K10 | 2.25444459 |
| 12 | RIPK1 | 1.86475121 |
| 13 | AKT3 | 1.82080086 |
| 14 | FGFR4 | 1.78834677 |
| 15 | PTK6 | 1.74503880 |
| 16 | FGFR3 | 1.69966426 |
| 17 | MAP3K7 | 1.65182443 |
| 18 | PIK3CG | 1.64266025 |
| 19 | PDGFRA | 1.55477190 |
| 20 | NLK | 1.50302849 |
| 21 | MAP3K14 | 1.48198971 |
| 22 | ERN1 | 1.48110912 |
| 23 | MAP4K1 | 1.47766812 |
| 24 | MTOR | 1.43988125 |
| 25 | TRPM7 | 1.40908501 |
| 26 | CDK6 | 1.38421874 |
| 27 | SGK3 | 1.37572010 |
| 28 | JAK1 | 1.36147686 |
| 29 | TGFBR2 | 1.35328905 |
| 30 | SCYL2 | 1.32680848 |
| 31 | MAP3K6 | 1.30433610 |
| 32 | DMPK | 1.27183792 |
| 33 | LMTK2 | 1.24096980 |
| 34 | KSR2 | 1.20767001 |
| 35 | FGFR2 | 1.20353044 |
| 36 | STK10 | 1.15729292 |
| 37 | STK3 | 1.14667788 |
| 38 | TAOK1 | 1.12291720 |
| 39 | BRD4 | 1.09195028 |
| 40 | TYK2 | 1.09182140 |
| 41 | SMG1 | 1.05235486 |
| 42 | CDK4 | 1.04610339 |
| 43 | ALK | 1.04514231 |
| 44 | FRK | 1.03498397 |
| 45 | PDGFRB | 1.02456632 |
| 46 | SIK2 | 1.01918559 |
| 47 | PDK4 | 1.01556130 |
| 48 | PDK3 | 1.01556130 |
| 49 | ICK | 1.01474750 |
| 50 | NEK1 | 0.99378336 |
| 51 | NEK2 | 0.98262407 |
| 52 | RET | 0.95060809 |
| 53 | YES1 | 0.94537296 |
| 54 | KSR1 | 0.92138756 |
| 55 | JAK3 | 0.88499409 |
| 56 | LRRK2 | 0.88014233 |
| 57 | SGK223 | 0.87497900 |
| 58 | SGK494 | 0.87497900 |
| 59 | BMX | 0.86427375 |
| 60 | STK38 | 0.85820590 |
| 61 | BTK | 0.84724162 |
| 62 | JAK2 | 0.84611625 |
| 63 | MAP2K3 | 0.82883514 |
| 64 | CLK1 | 0.82123655 |
| 65 | PRKAA2 | 0.81127337 |
| 66 | RIPK4 | 0.80530047 |
| 67 | PRKCH | 0.80081868 |
| 68 | CDC7 | 0.79774120 |
| 69 | ZAP70 | 0.78504945 |
| 70 | FGFR1 | 0.78463762 |
| 71 | CSF1R | 0.77618025 |
| 72 | PRKAA1 | 0.77234779 |
| 73 | INSRR | 0.74810532 |
| 74 | MAPK11 | 0.74774748 |
| 75 | CAMKK2 | 0.74772124 |
| 76 | RAF1 | 0.71782915 |
| 77 | RPS6KB1 | 0.70741724 |
| 78 | EPHB1 | 0.70272107 |
| 79 | MAP3K1 | 0.70064989 |
| 80 | SGK2 | 0.69358710 |
| 81 | BLK | 0.69087692 |
| 82 | MKNK2 | 0.69029835 |
| 83 | BMPR2 | 0.68796979 |
| 84 | NEK6 | 0.67570052 |
| 85 | ITK | 0.66149133 |
| 86 | CHEK1 | 0.65873015 |
| 87 | CDK9 | 0.63769410 |
| 88 | TEC | 0.63646631 |
| 89 | PIM1 | 0.63600824 |
| 90 | PDK1 | 0.63261309 |
| 91 | PAK2 | 0.63127968 |
| 92 | WNK1 | 0.62407274 |
| 93 | BRSK2 | 0.62288864 |
| 94 | TYRO3 | 0.62239833 |
| 95 | GRK6 | 0.62193415 |
| 96 | TAOK3 | 0.59590968 |
| 97 | MAPK10 | 0.58605176 |
| 98 | RPS6KB2 | 0.57730543 |
| 99 | FLT3 | 0.57268994 |
| 100 | HIPK2 | 0.55439852 |
| 101 | HCK | 0.54243032 |
| 102 | PHKG2 | 0.54020866 |
| 103 | PHKG1 | 0.54020866 |
| 104 | STK4 | 0.51905969 |
| 105 | CAMK4 | 0.51608250 |
| 106 | MKNK1 | 0.51528194 |
| 107 | NEK9 | 0.51116003 |
| 108 | CAMKK1 | 0.49913505 |
| 109 | CSNK1D | 0.49851643 |
| 110 | STK11 | 0.48317406 |
| 111 | ERBB2 | 0.47617685 |
| 112 | MAP3K8 | 0.47152676 |
| 113 | OBSCN | 0.46946786 |
| 114 | PRKD3 | 0.45582370 |
| 115 | PASK | 0.45049606 |
| 116 | MELK | 0.44914149 |
| 117 | MAP3K3 | 0.44405187 |
| 118 | CHUK | 0.43166302 |
| 119 | PRKD1 | 0.42893346 |
| 120 | IRAK1 | 0.42861180 |
| 121 | CDC42BPA | 0.42619099 |
| 122 | CSK | 0.41029655 |
| 123 | SGK1 | 0.40835185 |
| 124 | IKBKE | 0.40611430 |
| 125 | PDPK1 | 0.40510785 |
| 126 | LCK | 0.40061815 |
| 127 | SYK | 0.39949482 |
| 128 | BCKDK | 0.39827338 |
| 129 | MAP2K4 | 0.39012166 |
| 130 | PTK2 | 0.38935580 |
| 131 | MAPK12 | 0.38807142 |
| 132 | ATM | 0.38657132 |
| 133 | MARK3 | 0.38073276 |
| 134 | MARK2 | 0.38009215 |
| 135 | MAP3K2 | 0.37655095 |
| 136 | MAP3K13 | 0.37203822 |
| 137 | GSK3A | 0.37133420 |
| 138 | FES | 0.36980911 |
| 139 | * CDK2 | 0.36012953 |
| 140 | EPHA3 | 0.35047494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.05647398 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96053288 |
| 3 | Lysine degradation_Homo sapiens_hsa00310 | 2.42927071 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.41237746 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.32427085 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16181813 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.99807509 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.93155744 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.73596789 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69810852 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.66075906 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.61003049 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.60844990 |
| 14 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.59348899 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.56781569 |
| 16 | Thyroid cancer_Homo sapiens_hsa05216 | 1.55373062 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.52822174 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.52485757 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.50852008 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.47291101 |
| 21 | Insulin resistance_Homo sapiens_hsa04931 | 1.45837596 |
| 22 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.43149807 |
| 23 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.35280938 |
| 24 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.32679381 |
| 25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.29859208 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26992641 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25894414 |
| 28 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.24395229 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.24113392 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.22326774 |
| 31 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.20511581 |
| 32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.16626026 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16139354 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.15668046 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14184065 |
| 36 | Measles_Homo sapiens_hsa05162 | 1.12196831 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.11694459 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.11279280 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09837070 |
| 40 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.07953584 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 1.06541852 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05564632 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.02107710 |
| 44 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.01260079 |
| 45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97319350 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96410236 |
| 47 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.95819353 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95598604 |
| 49 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.94479741 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.94301636 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.94215077 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.93797465 |
| 53 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.93559620 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92837046 |
| 55 | Cell cycle_Homo sapiens_hsa04110 | 0.92523746 |
| 56 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92380831 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.90324008 |
| 58 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90200234 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.89379067 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89094919 |
| 61 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.88790444 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88518656 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88318537 |
| 64 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.88013321 |
| 65 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.87841541 |
| 66 | Adherens junction_Homo sapiens_hsa04520 | 0.87801421 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.86794922 |
| 68 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.86731008 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86703159 |
| 70 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.84915815 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84399428 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82371937 |
| 73 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81824672 |
| 74 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80609655 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.80567078 |
| 76 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79485204 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78823680 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77983369 |
| 79 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.77862425 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76912079 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75921204 |
| 82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.74768371 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.73831729 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.72354487 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71119644 |
| 86 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70484853 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.70425493 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70197554 |
| 89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69343009 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69284293 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68947255 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.68148834 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67705171 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.66890677 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66830410 |
| 96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66120879 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65913130 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63895573 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | 0.63264687 |
| 100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62820681 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62508821 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60952633 |
| 103 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59804134 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59747964 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57607782 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56425562 |
| 107 | Melanoma_Homo sapiens_hsa05218 | 0.55825493 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.53794644 |
| 109 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53495159 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52703045 |
| 111 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52244730 |
| 112 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51846045 |
| 113 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51597816 |
| 114 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51058194 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50494873 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50389054 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | 0.50108790 |
| 118 | Platelet activation_Homo sapiens_hsa04611 | 0.49683554 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49252450 |
| 120 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49225032 |
| 121 | Long-term depression_Homo sapiens_hsa04730 | 0.48968897 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48130337 |
| 123 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48104978 |
| 124 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46894847 |
| 125 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.46700621 |
| 126 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46594612 |
| 127 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46506415 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.45305495 |
| 129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42659373 |
| 130 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42378766 |
| 131 | Prostate cancer_Homo sapiens_hsa05215 | 0.42289068 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40392315 |
| 133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40092736 |
| 134 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38683839 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38660630 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37846393 |
| 137 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36975271 |
| 138 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.36280671 |
| 139 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35944983 |
| 140 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35826418 |
| 141 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34449189 |
| 142 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.33358918 |
| 143 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32732234 |
| 144 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32177817 |
| 145 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31654504 |

